Jpmorgan Chase & CO Senseonics Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 159,715 shares of SENS stock, worth $54,303. This represents 0.0% of its overall portfolio holdings.
Number of Shares
159,715
Previous 14,612
993.04%
Holding current value
$54,303
Previous $7,000
800.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SENS
# of Institutions
141Shares Held
59.8MCall Options Held
413KPut Options Held
212K-
Vanguard Group Inc Valley Forge, PA23.2MShares$7.88 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$2.83 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA7MShares$2.38 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA5.66MShares$1.92 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.11MShares$1.06 Million0.0% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $158M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...